Patient-Derived Xenograft Market Forecast 2024–2034
Market Overview The Patient-Derived Xenograft (PDX) Market is gaining strong momentum as precision oncology reshapes how cancer drugs are discovered and validated. PDX models, created by implanting patient tumor tissues into immunodeficient mice, closely mirror human tumor biology, making them invaluable for translational research and personalized medicine. Unlike conventional cell-line models,...
0 Commentarii 0 Distribuiri 20 Views 0 previzualizare
Sponsor